TORTI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 8.262
AS - Asia 5.258
EU - Europa 2.228
SA - Sud America 1.236
AF - Africa 136
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 11
Totale 17.146
Nazione #
US - Stati Uniti d'America 7.976
SG - Singapore 2.468
CN - Cina 1.128
IT - Italia 1.006
BR - Brasile 928
VN - Vietnam 561
IN - India 537
GB - Regno Unito 301
SE - Svezia 260
DE - Germania 219
CA - Canada 181
HK - Hong Kong 138
BD - Bangladesh 104
AR - Argentina 103
FI - Finlandia 82
MX - Messico 71
NL - Olanda 63
EC - Ecuador 60
ID - Indonesia 54
IQ - Iraq 53
RU - Federazione Russa 41
CO - Colombia 37
FR - Francia 37
VE - Venezuela 34
ZA - Sudafrica 33
TR - Turchia 32
UA - Ucraina 32
PL - Polonia 31
ES - Italia 30
PY - Paraguay 28
CZ - Repubblica Ceca 26
JP - Giappone 25
CL - Cile 24
UZ - Uzbekistan 22
EG - Egitto 21
RO - Romania 21
SA - Arabia Saudita 21
PK - Pakistan 20
KE - Kenya 18
TN - Tunisia 16
MA - Marocco 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
IE - Irlanda 10
PE - Perù 10
A2 - ???statistics.table.value.countryCode.A2??? 9
DZ - Algeria 9
AT - Austria 8
LT - Lituania 8
PH - Filippine 8
CR - Costa Rica 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
NG - Nigeria 7
UY - Uruguay 7
AU - Australia 6
AZ - Azerbaigian 6
CH - Svizzera 6
JO - Giordania 6
KZ - Kazakistan 6
AL - Albania 5
AM - Armenia 5
BG - Bulgaria 5
BO - Bolivia 5
EE - Estonia 5
EU - Europa 5
GR - Grecia 5
GT - Guatemala 5
JM - Giamaica 5
NP - Nepal 5
BY - Bielorussia 4
IR - Iran 4
KR - Corea 4
LB - Libano 4
NO - Norvegia 4
TW - Taiwan 4
BH - Bahrain 3
KG - Kirghizistan 3
KH - Cambogia 3
LV - Lettonia 3
MY - Malesia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
TO - Tonga 2
TZ - Tanzania 2
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
Totale 17.128
Città #
San Jose 1.626
Chandler 900
Singapore 892
Ashburn 765
Santa Clara 451
Bengaluru 398
Hefei 396
Dallas 374
Milan 347
Princeton 334
Lawrence 332
Chicago 225
London 222
Wilmington 216
Ho Chi Minh City 209
Munich 163
Beijing 150
Hong Kong 134
Ottawa 124
Hanoi 123
Des Moines 98
São Paulo 82
Los Angeles 75
Boardman 72
Turku 64
New York 63
Rome 62
Pune 36
Brooklyn 35
San Francisco 34
Shanghai 33
Guangzhou 32
Haiphong 32
Norwalk 32
Chennai 31
The Dalles 31
Catanzaro 29
Redwood City 29
Council Bluffs 28
Palermo 27
Rio de Janeiro 27
Olomouc 26
Da Nang 24
Warsaw 24
Guayaquil 23
Montreal 23
Baghdad 22
Mexico City 22
Woodbridge 22
Atlanta 21
Belo Horizonte 21
Tokyo 21
Crotone 20
Houston 20
San Nicola Manfredi 20
Tashkent 20
Wuhan 20
Thái Bình 19
Orem 18
Salvador 18
Stockholm 18
Boston 17
Fairfield 17
Helsinki 17
Naples 17
Buffalo 16
Porto Alegre 16
Quito 16
Nairobi 15
Phoenix 15
Amsterdam 14
Asunción 14
Brasília 14
Shenzhen 14
Bogotá 13
Charlotte 13
Cosenza 13
Jakarta 13
Piracicaba 13
Caracas 12
Curitiba 12
Hanover 12
Johannesburg 12
Rende 12
Rui'an 12
Seattle 12
Ankara 11
Biên Hòa 11
Redmond 11
Bari 10
Settingiano 10
Buenos Aires 9
Columbus 9
Denver 9
Dhaka 9
Guarulhos 9
Manchester 9
Miami 9
Mumbai 9
Padova 9
Totale 10.240
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 119
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 109
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 96
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 93
Increasing clinical virulence in two decades of the Italian HIV epidemic 86
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 83
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 82
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 81
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 80
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 78
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 77
Ochrobactrum anthropi 76
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 75
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 74
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 74
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 74
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 73
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 73
Use of colistin in adult patients: a cross-sectional study 73
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 69
Challenging clinical cases in HCV infection 69
Evolving phenotypes of non-hospitalized patients that indicate long COVID 69
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 68
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 68
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: Implications for timing to switch 68
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro 67
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 67
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 66
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 66
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 66
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 66
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 66
Allozyme divergence and phylogenetic relationships among species of tephritid flies 65
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 65
The role of Gram-negative bacteria in skin and soft tissue infections 64
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 64
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 64
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 64
Therapy with RAS inhibitors during the COVID-19 pandemic 64
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 63
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 63
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 63
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 63
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 63
A king in the CASTLE? Optimum initial HIV protease inhibitor. 62
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 62
RegaDB: community-driven data management and analysis for infectious diseases 62
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis. 62
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. 62
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 62
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 61
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 61
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 61
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 60
y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 60
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 60
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 60
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 60
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 59
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 59
Depression of lymphocyte activity during cutaneous leishmaniasis: a case report. 59
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 59
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 58
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 58
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 58
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 58
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 58
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 58
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 57
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 57
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium 56
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 56
HIV-1 pharmacoresistance: clinical and therapeutic implications 56
Genetic aspects of the worldwide colonization process of Ceratitis capitata 56
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 56
Weight of Clinical and Social Determinants of Metabolic Syndrome in People Living with HIV 56
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 55
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 55
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 55
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 55
Calendar Time Trends in the Incidence and Prevalence of Triple-Class Virologic Failure in Antiretroviral Drug-Experienced People With HIV in Europe 55
Virological Mechanisms in the Coinfection between HIV and HCV 55
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality 54
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 54
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 54
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 54
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 54
Factors influencing the normalization of CD4+T-cell count, percentage and CD4+/CD8+T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 54
Predictivity of frontal QRS-T angle for death in COVID-19 patients may differ by age 54
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 53
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naive Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 53
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 53
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 53
Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: An international multi-centre observational cohort study 52
Outcome of hbv screening and vaccination in a migrant population in southern italy 52
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 52
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 52
"Solving the puzzle" of current HAART: What key strategic trials are needed? 52
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia 52
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 52
Totale 6.389
Categoria #
all - tutte 177.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022880 9 3 12 236 30 17 41 216 58 104 146 8
2022/20232.569 684 110 20 276 286 244 14 160 402 169 166 38
2023/20241.126 236 146 78 76 69 288 36 24 26 25 60 62
2024/20253.713 542 273 136 136 235 459 67 142 458 232 333 700
2025/20268.498 396 1.060 751 1.405 724 312 1.261 489 1.038 719 268 75
Totale 17.395